Fundamentals-based quality & risk · not a recommendation
NGL Fine Chem Ltd scores 63/100 (Watch) on the Orion Score — moderate business quality (56), strong growth (87), strong balance-sheet safety (71) and rich valuation (39). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
83/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹149.23 | ₹13.49 | 11.0% | ₹21.83 |
| Q3 2026 | ₹127.51 | ₹15.69 | 13.4% | ₹25.40 |
| Q2 2026 | ₹120.26 | ₹9.63 | 10.0% | ₹15.58 |
| Q1 2026 | ₹104.19 | ₹9.24 | 6.4% | ₹14.96 |
| Q4 2025 | ₹94.97 | ₹0.54 | 3.2% | ₹0.88 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2026 | ₹500.95 | ₹48.13 | ₹87.42 | 10.6% |
| FY 2025 | ₹368.26 | ₹21.12 | ₹42.5 | 5.8% |
| FY 2024 | ₹333.71 | ₹41.32 | ₹67.4 | 12.6% |
| FY 2023 | ₹273.57 | ₹20.5 | ₹39.85 | 8.7% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| NGLFINE ★ | ₹1,694 Cr | 35.18 | 13.43% | 15.74% | 0.33x | 10.96% |
| SUNPHARMA | ₹4,27,609 Cr | 37.32 | 15.73% | 14.72% | 0.06x | 18.90% |
| MAXHEALTH | ₹95,110 Cr | 66.21 | 11.94% | 14.33% | 0.32x | 22.56% |
| AUROPHARMA | ₹88,148 Cr | 25.39 | 12.55% | 9.93% | 0.21x | 15.11% |
| ASTERDM | ₹68,390 Cr | 104.34 | 8.93% | 10.07% | 0.46x | 13.98% |
| ABBOTINDIA | ₹59,509 Cr | 38.28 | 36.31% | 34.46% | 0.04x | 27.01% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹433.39 | ₹355.54 | ₹287.08 | ₹276.93 |
| Equity | ₹282.43 | ₹262.63 | ₹222.55 | ₹203.22 |
| Total Debt | ₹77.1 | ₹34 | ₹32.5 | ₹30 |
| Cash | ₹0.58 | ₹0.4 | ₹7.83 | ₹0.64 |
| Net Debt | ₹76.51 | ₹33.61 | ₹24.67 | ₹29.36 |
| Working Capital | ₹116.41 | ₹126.08 | ₹104.36 | ₹107.84 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 72.74% | 0% | 0% | 27.26% |
| Q3 FY2026 | 72.74% | 0% | 0% | 27.26% |
| Q2 FY2026 | 72.74% | 0% | 0% | 27.26% |
| Q1 FY2026 | 72.74% | 0% | 0% | 27.26% |
| Q4 FY2025 | 72.74% | 0% ↓ | 0% | 27.26% ↑ |
| Q3 FY2025 | 72.74% | 0.05% ↑ | 0% | 27.23% ↓ |
| Q2 FY2025 | 72.74% | 0.02% | 0% | 27.25% ↑ |
| Q1 FY2025 | 72.74% | 0.03% | 0% | 27.24% |
No recent corporate actions
Ask: "Is NGL Fine Chem Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.